Patterns of glycemic control using glycosylated hemoglobin in diabetics

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 3, 2011, Pages 324-328

  Kahlon, Arunpreet Singh ^a   Pathak, Rambha ^a  

^a MAHARISHI MARKANDESHWAR INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Diabetes mellitus; glycosylated hemoglobin; Indian diabetic risk score

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; INDIAN DIABETES RISK SCORE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RURAL POPULATION; SCORING SYSTEM; SCREENING TEST; WAIST HIP RATIO;

EID: 80052781921     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.84431     Document Type: Conference Paper

References (25)

1. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7. (Pubitemid 34000780)
2. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R. Intra-urban differences in the prevalence of the metabolic syndrome in Southern India-the Chennai Urban Population study. Diabet Med 2001;18:280-7. (Pubitemid 32579357)
3. Mohan V, Jaydip R, Deepa R. Type 2 diabetes Asian Indian youth. Pediatr Diabetes 2007;8 Suppl 9:28-34. (Pubitemid 350066645)
4. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101.
5. Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, et al. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: Prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004;66:301-7. (Pubitemid 39469376)
6. Anand K, Shah B, Gupta V, Khaparde K, Pau E, Menon GR, et al. Report of the surveillance of risk factors of non-communicable diseases (STEPS 1 and 2) from five centres in India. WHO India: ICMR initiative; 2006.
7. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med 2004;140:945-50. (Pubitemid 38685285)
8. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 1995;18:1270-3.
9. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002;25:829-34. (Pubitemid 41094278)
10. Heine RJ, Mooy JM. Impaired glucose tolerance and unidentified diabetes. Postgrad Med J 1996;72:67-71. (Pubitemid 26048223)
11. Samuels TA, Cohen D, Brancati FL, Coresh J, Kao WH. Delayed Diagnosis of Incident Type 2 Diabetes Mellitus in the ARIC Study. Am J Manag Care 2006;12:717-24. (Pubitemid 44955867)
12. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A New Look at Screening and Diagnosing Diabetes Mellitus. J Clin Endocrinol Metab 2008;93:2447-69.
13. Liberopoulos EN, Florentin M, Kei A, Mountzouri E, Agouridis A, Elisaf MA. Comparison of Hemoglobin A1c and Fasting Glucose Criteria to Diagnose Diabetes Among People With Metabolic Syndrome and Fasting Glucose Above 100 mg/dL (5.5 mmol/L). J Clin Hypertens (Greenwich) 2010;12:543-8.
14. Motta M, Bennati E, Cardillo E, Ferlito L, Malaguarnera M. The value of glycosylated hemoglobin as a predictive risk factor in the diagnosis of diabetes mellitus in the elderly. Arch Gerontol Geriatr 2010;50:60-4.
15. Hashimoto Y, Futamura A, Watanabe N, Togo M, Sato H, Hara M, et al. Relationship between glycosylated hemoglobin and the prevalence of proteinuria in Japanese men. Intern Med 1999;38:6-11.
16. Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A Simplified Indian Diabetes Risk Score for Screening for Undiagnosed Diabetic Subjects. J Assoc Physicians India 2005;53:759-62.
17. Powers AC. Diabetes mellitus. In: Fauci AS, editor. Harrison's principles of Internal medicine. U.S.A: Mc GrawHill; 2009. p. 2275-304.
18. Reynolds TM, Smellie WS, Twomey PJ. Glycated Hemoglobin monitoring. BMJ 2006;333:586-8.
19. American college of endocrinology consensus statement on guidelines for glycemic control. Endocr Pract 2002;8(suppl 1):5-11.
20. Qvist R, Shah I, Ismail, Chinna K, Muniandy S. Use of Glycated hemoglobin and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population. Indian J Clin Biochem 2008;23:246-9.
21. Malati T, Krishna DM, Srinivasan VR, Shantharam V. Glycosylated hemoglobin a ∼ in a random group of adult onset diabetics of Indian subpopulation. Indian J Clin Biochem 1992;7:138-42. (Pubitemid 23055766)
22. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E. Use of HBa1c in predicting progression to diabetes in French men and women. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006;29:1619-25.
23. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for False-Positive Diagnoses of Type 2 Diabetes Using New Diagnostic Criteria. JAMA 1999;281:1203-10. (Pubitemid 29163129)
24. Mulkerrin EC, Arnold JD, Dewar R, Sykes D, Rees A, Pathy MS. Glycosylated hemoglobin in the diagnosis of diabetes mellitus in elderly people. Age Ageing 1992;21:175-7.
25. Yoshinaga H, Kosaka K. High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance. Diabetes Res Clin Pract 1996;31:71-9. (Pubitemid 26179914)